Travere Therapeutics: Strong Growth and Strategic Advancements Drive Buy Rating
Analyst Edward Nash from Canaccord Genuity maintained a Buy rating on Travere Therapeutics (TVTX – Research Report) and keeping the price ...
Travere Therapeutics (TVTX) Gets a Buy from TD Cowen
In a report released today, Tyler Van Buren from TD Cowen maintained a Buy rating on Travere Therapeutics (TVTX – Research Report), with ...